Table 3. Adjusted HRs for the presence of MACE and all-cause mortality during 1 year.
MACE | All-cause mortality | |||
---|---|---|---|---|
Adjusted HR (95% CI) | p | Adjusted HR (95% CI) | p | |
Age, 10 years | 1.64 (1.23–2.20) | 0.001 | 1.72 (1.19–2.48) | 0.004 |
Sex (male) | 1.31 (0.62–2.77) | 0.482 | 1.57 (0.65–3.80) | 0.314 |
BMI | 0.95 (0.86–1.04) | 0.256 | 0.83 (0.73–0.94) | 0.003 |
Hypertension | 1.16 (0.48–2.83) | 0.746 | 1.45 (0.51–4.09) | 0.486 |
Diabetes | 0.75 (0.36–1.54) | 0.429 | 1.37 (0.58–3.22) | 0.469 |
Current smoking | 1.20 (0.57–2.51) | 0.627 | 1.14 (0.47–2.79) | 0.776 |
Antihypertensive use | 0.91 (0.39–2.14) | 0.826 | 0.76 (0.29–1.97) | 0.570 |
Statin use | 0.89 (0.37–2.18) | 0.801 | 1.04 (0.36–3.03) | 0.940 |
Antithrombotics use | 0.31 (0.06–1.91) | 0.185 | 0.28 (0.05–1.96) | 0.197 |
LDL-C (mg/dL) | 1.00 (0.99–1.01) | 0.508 | 1.00 (0.99–1.01) | 0.720 |
Initial glucose (mg/dL) | 1.00 (1.00–1.01) | 0.704 | 1.00 (0.99–1.01) | 0.923 |
Creatinine (mg/dL) | 1.17 (0.95–1.43) | 0.132 | 1.22 (0.98–1.53) | 0.078 |
CRP (mg/dL) | 1.04 (0.97–1.11) | 0.247 | 1.08 (1.02–1.15) | 0.005 |
Admission NIHSS | 1.04 (0.99–1.10) | 0.099 | 1.14 (1.08–1.20) | <0.001 |
LVEF, 10% | 0.54 (0.36–0.80) | 0.002 | 0.61 (0.39–0.97) | 0.037 |
BMI = body mass index; CI = confidence interval; CRP = C-reactive protein; HR = hazard ratio; LDL-C = low-density lipoprotein cholesterol; LVEF = left ventricular ejection fraction; MACE = major adverse cardiovascular events; NIHSS = National Institutes of Health Stroke Scale.